Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-22, Stock:LLY, The news for the past five days is as follows:
2019-05-15: NEWS1: Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer.NEWS2: 3 Stocks With Big News Coming at ASCO 2019.NEWS3: 3 Stocks With Big News Coming at ASCO 2019.NEWS4: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS5: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS6: 3 Top Diabetes Stocks to Watch in May.NEWS7: 3 Top Diabetes Stocks to Watch in May.NEWS8: 3 Stocks With Big News Coming at ASCO 2019.NEWS9: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS10: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS11: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS12: 3 Top Diabetes Stocks to Watch in May.NEWS13: Lilly to Participate in Bank of America Merrill Lynch Health Care Conference.
2019-05-16: NEWS1: Lilly to Participate in UBS Global Healthcare Conference.NEWS2: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.NEWS3: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.NEWS4: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.
2019-05-17: NEWS1: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS2: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS3: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.
2019-05-20: NEWS1: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS2: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS3: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock.NEWS4: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS5: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS6: Interesting LLY Put And Call Options For August 16th.NEWS7: Interesting LLY Put And Call Options For August 16th.NEWS8: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.
2019-05-21: NEWS1: Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled.NEWS2: Here's Why Array BioPharma Is Surging Today.NEWS3: Here's Why Array BioPharma Is Surging Today.NEWS4: Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions.NEWS5: Merck agrees $1bn deal to buy biopharmaceutical company Peloton.

Answer: Rise